Schlafen 5 is an intracellular immune checkpoint and controls IFN responses in pancreatic ductal adenocarcinoma
JCI Insight · 09.03.2026 · 11 (5)
DOI: 10.1172/jci.insight.190031 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 27.01.2026. Verfasst von Mariafausta Fischietti und 16 weiteren Autor:innen. Beteiligte Einrichtung: Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Interferon Type I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, NINDS.
Abstract (Originalsprache)
We provide evidence that human and murine Schlafen 5 (SLFN5) proteins are modulators of type I IFN responses and the immune response in pancreatic ductal adenocarcinoma (PDAC). Blocking expression of Slfn5 in PDAC enhanced IFN responses, suppressed tumor growth, and prolonged survival in immunocompetent mice. Notably, immunophenotypic analysis revealed a reduction in tumor-associated macrophages alongside an increase in tumor-infiltrating effector cells in tumors over time. These findings suggest SLFN5 acts as an intracellular immune checkpoint and identify it as a unique therapeutic target for the development of therapies for PDAC and possibly other malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.
- Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, USA.
- Department of Neurological Surgery.
- Department of Biochemistry and Molecular Genetics, and.
- Division of Biostatistics, Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- NINDS
- NCI
Zitieren
APA
Fischietti, M., Zannikou, M., Beauchamp, E. M., Saleiro, D., Baran, A. H., Hryhorysak, B. N., Magaña, J. N. G., Fajardo, E. L., Blyth, G. T., Castro, B. A., Miska, J. M., Lee-Chang, C., Patel, P., Bartom, E. T., Kocherginsky, M., Eckerdt, F., & Platanias, L. C. (2026). Schlafen 5 is an intracellular immune checkpoint and controls IFN responses in pancreatic ductal adenocarcinoma. JCI Insight, 11(5). https://doi.org/10.1172/jci.insight.190031
Vancouver
Fischietti M, Zannikou M, Beauchamp EM, Saleiro D, Baran AH, Hryhorysak BN, et al. Schlafen 5 is an intracellular immune checkpoint and controls IFN responses in pancreatic ductal adenocarcinoma. JCI Insight. 2026;11(5). doi:10.1172/jci.insight.190031
BibTeX
@article{Fischietti2026,
author = {Fischietti, Mariafausta and Zannikou, Markella and Beauchamp, Elspeth M and Saleiro, Diana and Baran, Aneta H and Hryhorysak, Briana N and Magaña, Jamie N Guillen and Fajardo, Emely Lopez and Blyth, Gavin T and Castro, Brandyn A and Miska, Jason M and Lee-Chang, Catalina and Patel, Priyam and Bartom, Elizabeth T and Kocherginsky, Masha and Eckerdt, Frank and Platanias, Leonidas C},
title = {Schlafen 5 is an intracellular immune checkpoint and controls IFN responses in pancreatic ductal adenocarcinoma},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {5},
doi = {10.1172/jci.insight.190031}
}
EUVIMED